The platform pursues three central goals: Firstly, it aims to shorten the often years-long search for a diagnosis so that patients receive clarity and a well-founded assessment more quickly. Secondly, patients who have already been diagnosed will be referred to suitable clinical trials. Thirdly, the entire path from initial examination to optimal treatment will be accelerated in order to improve the quality of life of those affected and, in the best case, save lives.
Saventic Care is user-friendly and completely free of charge. Patients can securely fill out a questionnaire and upload their medical documents. A double evaluation is then carried out: firstly by state-of-the-art AI algorithms and secondly by a team of experienced medical specialists from various medical disciplines who specialise in rare diseases. This combined analysis significantly shortens the diagnostic process and ensures that patients with a suspected rare disease are quickly referred to suitable treatment centres.
"On the Saventic Care website, you simply fill out the form and upload relevant medical documents," explains Szymon Piątkowski, CEO and founder of Saventic Health. "After the analysis - both by our algorithms and by experienced specialists - we inform patients whether they are at risk of a rare disease and which centre or specialist they can contact. Each case is considered individually so that alternative health problems are also recognised and addressed promptly."
The challenge of diagnosing rare diseases is enormous. "You could say that these diseases are not that rare - the actual extent and individual significance is much greater than it appears," says Prof Janina Müller-Deile. "By definition, rare diseases affect less than 1 in 5,000 people. However, there are almost 8,000 different rare diseases, meaning that an estimated 6-8% of the population suffer from a rare disease. Due to non-specific symptoms, which are often confused with more common diseases, and the low prevalence of each disease, diagnosis is often a lengthy, costly and frustrating process. Far too often, the cause of symptoms caused by rare diseases is recognised too late, meaning that targeted treatment is delayed by years or even decades and the disease progresses. It is therefore all the more important to speed up the diagnostic process and protect patients from misdiagnoses and misdirected treatment."
Currently, Saventic Care supports the diagnosis of the following rare diseases: Fabry disease, Gaucher disease, HAE, PNO, amyloidosis, Castelman disease, MPS, PNH, HPP, EGPA and LAL-d. The aim is to continuously expand the spectrum.
Since its foundation in Poland, Saventic Health has expanded its reach to major countries such as Germany, Canada, Brazil and other regions in Latin America. The platform is currently available in English, German, Portuguese, Spanish and Polish, with further language versions planned. The aim is to give even more patients worldwide access to a rapid diagnosis. Over 3,000 patients have already used the online form and more than 500,000 people have accessed the website.
In the past year alone, Saventic Health's AI algorithms have helped to refer over 300 people with suspected rare diseases to specialist doctors and reference centres. The company focuses on holistic care: every patient receives individualised feedback. Even if no rare disease is detected, alternative health problems are identified and patients are referred to appropriate specialists. This emphasises Saventic Health's commitment to improving the lives of those affected and their families in the long term.Do you suspect that you may be suffering from a rare disease? Start your journey to diagnosis today at
www.saventiccare.de
Press contact:
Aneta Matysiak-Świątek
aneta.matysiak@saventic.com
+49 (0)151 215 98 022
